AI-generated summary
The authors studied mice given MPTP, a toxin that models Parkinson's disease, and applied 670nm and 810nm near infrared light to the skull, alone or together. They report that applying both wavelengths sequentially gave greater gains in locomotor activity and tyrosine hydroxylase-positive cells in the substantia nigra than either wavelength alone or concurrent application. The study is in mice, so findings may not transfer to humans.
- Who or what was studied
- MPTP-treated mice (mouse model of Parkinson's disease)
- Wavelengths
- 670, 810 nm
- Limits stated in the abstract
- The study was conducted in a mouse model, and the abstract does not report the number of animals per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670nm, 810nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.